首页> 外文期刊>BBA Clinical >Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?
【24h】

Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?

机译:骨化三醇/骨化二醇比率:维生素D羟基化效率的指标?

获取原文
       

摘要

Background Calcifediol (25D) availability is crucial for calcitriol (1,25D) synthesis, but regulation of vitamin D hydroxylases is majorly responsible for 1,25D synthesis. The net efficiency of vitamin D hydroxylases might be informative. We assume that the ratio between calcitriol and calcifediol (25D/1,25D) serum concentrations could suggest the vitamin D hydroxylation efficiency. Methods We evaluated 25D/1,25D in different patient populations: hemodialysis (HD, n = 76), {CKD} stage 2–5 (n = 111), renal transplant (TX, n = 135), patients with no renal disease (No-CKD, n = 290), and primary hyperparathyroidism (PHP, n = 20). Results The geometric mean of 1,25D/25D (pgg) averaged 1.11 (HD), 1.36 (CKD), 1.77 (TX), 2.22 (No-CKD), and 4.11 (PHP), with a progressive increment from {HD} to {PHP} (p-value for the trend <0.001). Each clinical condition elicited a significant effect on 25D/1,25D (p < 0.0001) and adjusted multivariate analysis indicated levels of Cas, Ps, PTH, and 25D as predictors of 25D/1,25D. Both in vitamin D deficient and replete subjects (25D< or ≥20 ng/ml) 25D/1,25D associated with each clinical condition (p < 0.0001) and mean values increased progressively from {HD} to {PHP} (p-values for the trend <0.0001). Regression analysis between 25D (substrate) and 25D/1,25D (efficiency) revealed an exponential negative correlation in No-CKD (r2Exp = 0.53, p < 0.001) with sharp increments of 25D/1,25D when 25D values are <20 ng/ml. At variance, in {CKD} (r2lin = 0.19) and in {TX} (r2lin = 0.32) the regression was linear as if, in case of deficit, some inhibition of the system were operating. Conclusion and General significance In conclusion 1,25D/25D can reflect the efficiency of vitamin D hydroxylases more than separate evaluation of 25D and 1,25D and can facilitate the therapeutic choices in different patient populations.
机译:背景技术Calcifediol(25D)的可用性对骨化三醇(1,25D)的合成至关重要,但是维生素D羟化酶的调节主要负责1,25D的合成。维生素D羟化酶的净效率可能是有益的。我们假设骨化三醇和骨化三醇的比例(25D / 1,25D)可以提示维生素D的羟化效率。方法我们评估了不同患者人群的25D / 1,25D:血液透析(HD,n = 76),{CKD} 2–5期(n = 111),肾移植(TX,n = 135),无肾脏疾病的患者(无CKD,n = 290)和原发性甲状旁腺功能亢进症(PHP,n = 20)。结果1,25D / 25D(pg / ng)的几何平均值分别为1.11(HD),1.36(CKD),1.77(TX),2.22(No-CKD)和4.11(PHP),且从{ HD}至{PHP}(趋势的p值<0.001)。每种临床状况均对25D / 1,25D产生显着影响(p <0.0001),调整后的多元分析表明,Cas,Ps,PTH和25D的水平可作为25D / 1,25D的预测指标。维生素D缺乏者和充足者(25D <或≥20ng / ml)的25D / 1,25D与每种临床状况有关(p <0.0001),并且平均值从{HD}逐渐增加到{PHP}(p值趋势<0.0001)。 25D(底物)和25D / 1,25D(效率)之间的回归分析显示,当25D值<20 ng时,No-CKD呈指数负相关(r2Exp = 0.53,p <0.001),且25D / 1,25D急剧增加。 /毫升。在方差方面,在{CKD}(r2lin = 0.19)和{TX}(r2lin = 0.32)中,回归是线性的,就好像在出现缺陷的情况下,系统正在起作用。结论和一般意义总而言之,与单独评估25D和1,25D相比,1,25D / 25D可以更好地反映维生素D羟化酶的效率,并且可以促进不同患者群体的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号